GlassScriptPhysician profile
Steven John Reto
NPI 1093750739
$1,422.55
in general payments reported to CMS, 2019-2025
17 companies · $237 in 2025
The $237 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $95.32 · 2021: $36.00 · 2022: $275 · 2023: $21.93 · 2024: $432 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $690.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $282.78 | 2024-2025 | Total30, Clareon |
| Coopervision INC. | $230.42 | 2019-2024 | Myday Contact Lens |
| Quidel Corporation | $171.13 | 2019-2022 | |
| Ortho-Clinical Diagnostics, INC. | $148.51 | 2024 | Inflammadry |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $125.52 | 2019 | |
| Allergan, INC. | $113.59 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $71.38 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $49.06 | 2024-2025 | Vevye |
| Johnson & Johnson Vision Care, INC. | $42.69 | 2024 | |
| Sun Pharmaceutical Industries INC. | $36.29 | 2019 | |
| Dompe US, INC. | $31.60 | 2025 | Oxervate |
| Abbvie INC. | $31.38 | 2022 | |
| Bausch & Lomb Americas INC. | $22.56 | 2025 | Miebo |
| Novartis Pharmaceuticals Corporation | $22.07 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maculogix, INC. | $12.62 | 2020 | |
| Lkc Technologies, INC. | $11.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Reto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.